Michael Macaluso's Net Worth
$7.96 Million
Who is Michael Macaluso?
Michael Macaluso has an estimated net worth of $7.96 Million. This is based on reported shares across multiple companies, which include ISOLAGEN INC, AYTU BIOPHARMA, INC, and Ampio Pharmaceuticals, Inc..
SEC CIK
Michael Macaluso's CIK is 0001096423
Past Insider Trading and Trends
2016 was Michael Macaluso's most active year for acquiring shares with 5 total transactions. Michael Macaluso's most active month to acquire stocks was the month of June. 2013 was Michael Macaluso's most active year for disposing of shares, totalling 3 transactions. Michael Macaluso's most active month to dispose stocks was the month of June. 2013 saw Michael Macaluso paying a total of $47,913.25 for 27,379 shares, this is the most they've acquired in one year. In 2004 Michael Macaluso cashed out on 400,000 shares for a total of $2,532,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ISOLAGEN INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -51.56% | -400.00K |
$6.33 | -$2,532,000.00 | 375.73K |
Nov 3
| |||
| No matching records found | |||||||||
AYTU BIOPHARMA, INC (AYTU) Snapshot price: $2.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +926.28% | 187.8K |
—
|
—
| 208.08K |
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| +7,304.60% | 200K |
—
|
—
| 202.74K |
Oct 24
| |||
Form 4
| +1,055.07% | 50K |
—
|
—
| 54.74K |
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
| +218.27% | 65K |
—
|
—
| 94.78K |
Jul 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ampio Pharmaceuticals, Inc. (AMPE) Snapshot price: $1.8507
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.54% | -68.40K |
$0.57 | -$38,988.00 | 2.62M |
Jan 1
| |||
Form 4
| -1.59% | -43.47K |
$1.64 | -$71,290.80 | 2.69M |
Oct 27
| |||
Form 4
| +53.17% | 950K |
—
|
—
| 2.74M |
Oct 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
| +1.56% | 27.38K |
$1.75 | $47,913.25 | 1.79M |
Nov 27
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -13.90% | -284.00K |
—
|
—
| 1.76M |
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
| +0.11% | 2.27K |
$4.41 | $10,001.88 | 2.04M |
Jan 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||